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S_in.ary Clonal interaction between three subpopulations of Ehrlich carcinoma were studied during growth
as mixed solid tumours and as ascites tumours in immune-incompetent nude NMRI mice. The tumour cell
lines differed in DNA content as determined by DNA flow cytometry (FCM). Tumour growth was evaluated
by tumour growth curves including cakulation of tumour volume doubling times, tumour weight on day 14,
cell cycle times (per cent labelled mitoses) and cell cycle distributions (FCM). Two subpopulations (E1.15 and
E1.95) showed nearly identical growth characteristics during both solid and ascites tumour growth. The third
subpopulation (E1.80) grew more slowly. FCM on fine-needle tumour aspirates was used to determine the
relative proportions of the cell populations in mixed solid tumours in which E1.95 showed a growth-
dominating effect on E1.15. No such effect was demonstrated during single-cell tumour growth in ascitic fluid
in which the cells had no intimate contact. Ascitic fluid from El.95-bearing animals or radiation-kiled E1.95
cells had no effect on the growth of El.15, and no remote effect was seen when the two cell lines were growing
in opposite flanks. This indicates that only viable E1.95 cells in close in vivo contact were able to induce
growth inhibition of the E1.15 subpopulation. Both the E1.95 and the El.15 cells dominated the E1.80 cells,
but in these cases cell kinetic differences may have played a role as the E1.95 and the E1.15 lines grew faster
than the E1.80. The E1.80 cell line had no dominating effect on the E1.15 or E1.95. It is concluded that
non-immunologically mediated cellular dominance in heterogeneous tumours may contribute to the evolution
of these tumours and may be involved in fundamental tumour biological phenomena.
During tumour evolution, genetic changes may lead to
emergence of new tumour cell subpopulations with diverging
phenotypic characteristics (Nowell, 1976), thus resulting in a
heterogeneous mixture of cells differing in immunogenic pro-
perties, in metastatic ability and in responsiveness to
cytotoxic agents. In heterogeneous tumours, little is known
about the implications of such interaction between sub-
populations for the further evolution of the tumour. In
previous studies we have shown that an immunogenic Ehrlich
carcinoma subpopulation grown in close contact with non-
immunogenic subpopulations subcutaneously was able to
induce an immunological response against the non-immuno-
genic populations in immune-competent mice (Aabo et al.,
1987, 1989). Further, a non-related P388 leukaemia cell line
was able to dominate both the immunogenic and the non-
immunogenic Ehrlich cell lines when grown in mixed solid
tumours. This domination did not involve an immune reac-
tion and required close in vivo cellular contact (Aabo et al.,
1989).
Clonal interaction between tumour cell subpopulations has
been reported in other munrne tumours (Miller et al., 1987,
1988; Korczak et al., 1988; Ichikawa et al., 1989; Enoki et
al., 1990; Staroselsky et al., 1990; Samiei & Waghorne, 1991)
as well as in human tumour systems (Leith et al., 1985, 1987;
Staroselsky et al., 1992).
We here report on the interaction of three sublines of
Ehrlich carcinoma in immune-incompetent athymic nude
mice in which no immune reaction to the cell lines was
elicited.
Materiak and metbod
Experimental design
Mixtures of three Ehrlich carcinoma cell lines which were
distinguishable by flow cytometric DNA analysis because of
differences in their DNA content were inoculated sub-
cutaneously in nude mice. After 2 weeks of tumour growth,
the mice were killed and the tumours were excised and
weighed. Fine-needle tumour biopsies were prepared for flow
cytometric DNA analysis in order to determine the relative
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proportions of tumour cells in the tumours. In addition to
the day 14 tumour weights, tumour growth was monitored
by tumour growth curves, cell cycle distributions determined
by flow cytometric DNA analysis and cell cycle times deter-
mined by per cent labelled mitoses. Changes in the relative
fractions of tumour cells in the tumours, or changes in the
tumour growth pattern, made it possible to investigate
tumour cell interactions in heterogeneous tumours during
solid tumour growth in vivo.
In order to evaluate tumour cell interaction during in vivo
single-cell growth, i.e. the tumour cells having no close con-
tact, mixtures of tumour cells were inoculated intra-
peritoneally. After 7 days the animals were killed, and ascites
containing the tumour cells was harvested. The number of
tumour cells in animals inoculated with non-mixed cells
served as a growth parameter. The relative fractions of
tumour cells in the mixed ascites tumours were examined by
flow cytometric DNA analysis.
In order to examine the effect of non-viable cells on viable
cells in mixed tumours, cells of one subpopulation were
radiated before they were mixed with viable cells of another
subpopulation and injected subcutaneously. Also, the effect
of cell-free ascitic fluid on viable tumour cells was examined.
Cell lines
Three Ehrlich carcinoma lines were used. From an Ehrlich
wild-type (NCI) cell line which had been kept in serial pas-
sage intraperitoneally in N/D mice for many years, a
vinblastine-resistant and a daunomycin-resistant cell line were
originally developed by repeated intraperitoneal injections of
these drugs (Dan0, 1972). These cell lines have been serially
transplanted intraperitoneally over a period of many years.
The cell lines differed in DNA content. DNA indices (see
below) as determined by flow cytometric DNA analysis were
1.95 for Ehrlich wild-type (El.95), 1.15 for the vinblastine-
resistant line (El.15) and 1.80 for the daunomycin-resistant
line (El.80), with normal diploid mouse cells being 0.95 and
human lymphocytes being 1.00.
Mice
Six-week-old athymic nude male NMRI mice (Bomholtgaard
Breeding and Research Centre, Ry, Denmark) were used as
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tumour-bearing hosts. The animals were kept under sterile
conditions in laminar air flow benches and aSlowed stilised
food and water ad libitwn.
Cell suspensions
The tumour cell-containing ascites was harvested with a
sterile pipette 7-8 days after intraperitoneal transplantation
and transferred to sterile test tubes connng 0.3 ml of a
benzylpenicillin solution (= 150 IU) and 0.3 ml of heparin
solution (= 8 IU). The cells were washed once (230g for
5 min) in sterile Ca2+- and Mg2+-free isotonic phosphate-
buffered saline (PBS), pH 7.3, resuspended in PBS and
adjusted to 7.5 x 107 cells per ml of PBS. Before inoculation,
the cells were mixed in pairs in 1:1 proportions. Approx-
imately 10' cells were prepared for flow cytometric DNA
analysis. Cell viability was examined by the nigrosin dye
exclusion test. The percentage of non-viable cells was less
than 5% for all cell lines. A 0.2 ml aliquot of the mixed cell
suspensions was inoculated subcutaneously in the right flani
ofnine nude NMRI mice. Controls of all three cell lines were
inoculated in equivalent cell numbers.
Measurement of tunour growth
The tumour size was expressed as the product of two perpen-
dicular tumour diameters (mm2) measured by callipers
approximately three times a week. Median tumour growth
curves were used to describe tumour growth. Furthermore,
animals were klcled 14 days after tumour cell inoculation,
and the tumours were excised and weighed. Using a com-
puter program (Rygaard & Spang-Thomsen, 1989), the
median tumour volume doubling times at a preseected
tumour volume of 350mm3 were calculated.
Fow cytometric DNA analysis (FCM)
Samples from tumour cell suspensions (ascites) and from
fine-needle tumour aspirates were analysed by FCM usng a
FACS III (Becton Dickinson, Sunnyvale, CA, USA)
(Vindel0v & Christensen, 1990). The cell cycle distributions
in unmixed control tumours and the proportions of each
tumour cell line and of diploid mouse cells in the mixed
tumours were esimated by statistical analysis of the DNA
histograms using a maximum likelihood method (Vindel0v &
Chsense, 1990). The DNA index of the tumour cells was
determined as the ratio of the DNA content of the tumour
Go + G, cells to that of human diploid cells by the use of
chicken and trout red blood cells as internal references
(Vindelov et al., 1983).
Per cent labelled mitoses (PLM)
The tumour cells were inoculated in both flanks of the mice.
Fourteen days after tumour cell inoculation, 40#Ci of 3H-
labelled thymidine (specific activity 6.7 Ci mmol', New Eng-
land Nuclear) was intraperitoneally to the mice.
At intervals after the pulse labelling the mice were kiled. The
tumours were excised and immediately fixed in 4% buffered
formaldehyde. Autoradiographs were prepared as previously
described (Aabo et al., 1989). One hundred consecutive
mitoses were examined for labelling in resentative areas of
the tumour. Thus the number of labelled mitoses was the
PLM. Mitoses labelled by four or more grains were con-
sided labelled. This detection limit was based on the com-
parison with the background labelling in sectons from
umlabelled tumours. If labelling had failed, that is if no
labelling was present in the basal cells of the epidermis, the
procedure was repeated in order to obtain a new pair of
PLM data at that particular time point. The PLM data were
analysed by a computer program (Steel & Hanes, 1971)
calulating the duration of the post-mntotic phase, TGI, the
DNA synthesis phase, Ts, the premitotic gap phase, TG2, and
the median cell generation time, Tc, together with the fre-
quency distribution of Tc.
Ascites
Cell-free ascites from E1.95 was prepared by centrifugation
for 5 min at 230g of the harvested tumour ceUl containing
ascites followed by a subsequent centrifugtion of the super-
natant at 2,700 g for 20min. Finally, the ascites was
irradiated with a single X-ray dose of 120Gy.
Irradiation
A E1.95 cel suspension was irradiated with a single X-ray
dose of 120 Gy using a Stabilipan (Siemens). The dose rate
was 5.32 Gymini ± 2% at 300kV and 8 mA using a
Thoreus I filter. After this dose of irradiation, the tumour
take rate was 0.
RemIs
Tumourgrowth
Figure 1 shows the median tumour growth curves of the
three cell lines studied in nude mice. The medan growth
curves of El.15 and E1.95 were nearly identical, whereas the
E1.80 cell line grew more slowly. The El.15 tumours were
highly infiltrating, causing superior caval vein syndrome as a
result of infiltation of the superior thoracic aperture. Thus,
it was only possible to observe El.15 tumour growth for 15
days, after which the animals died from this complication.
From Table I it appears that the tumour weights on day
14 were siilar for E1.15 and E1.95, whereas E1.80 grew to a
smaller size, supporting the growth curve data. The mixed
tumours El.15/El.95 and E.1.15/El.80 grew similarly to
E1.95 and to E1.80 respectively. Tumours composed of a
mixture of E1.95 and E1.80 grew to a size which approx-
imately was the sum of the weights of E1.95 and E1.80
tumours. Iradiated E1.95 and cell-free ascites from E1.95-
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Figwe I Median tumour growth curves of three Ehrlich car-
cinoma fines, E1.15 (V), E1.80 (A) and E1.95 (0), grown as
subcutaneous tumours (40 tumours in each group) in nude mie.
Tumour size is expressed as the product of the nasuremet of
two peirpendular diame The E1.15 tumours could only be
folowed for 15 days, after which time the aniTals died as a result
of tumour infiltration in the upper thoracic apertre.
Tab I Tumour weights ofE1.15, E1.80 and E1.95 control tumours
and ofmixed tumours 14 days after cell inoculation
Tumour weight on day 14 (g)
Tunour n Median Range
E.1.15 9 1.4 0.5-4.9
E.1.80 9 0.8 0.4-2.9
E.1.95 9 1.3 0.6-4.7
E.1.15/EI.80 9 1.2 0.4-3.5
E.1.15/E1.95 9 1.3 0.5-42
E.1.80/E1.95 9 2.7 1.3-7.7
E.1.15 (E1.95 opposite) 9 1.5 0.5-4.2
E.1.15/irradiated E1.95 9 1.2 0.6-4.0
E.1.15/ascites El.95 9 1.3 0.6-4.6
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Table Cell cycle distributions ofthree Ehrlich carcinoma lines (El.15, El.80 and El.95) as measured by flow cytometric DNA
analysis on fine-needle tumouraspirates 14days after tumourcell inoculationand on tumourcell-containing ascites 7 daysafteri.p.
inoculation ofEl.15andE1.95. Medianvaluesand rangeofnine tumoursineachgroup. Mediancell cycletimesinhoursdetermined
by PML and median tumour volume doubling times in days determined from the growth curves are also given
Median cell cycle times Median tunour
Median cell cycle distributions (%) (range) (h) volune doubling
Cell line DNA index Go + GI S Gz + M TC TGI TS TG2 time (days)
E1.15 (solid) 1.15 44 (36-56) 42 (34-54) 14 (3-14) 17.5 3.8 7.3 5.2 3.09
E1.80 (solid) 1.80 59 (53-70) 36 (25-39) 5 (5-13) 22.0 4.5 10.6 4.7 5.13
E1.95 (solid) 1.95 43 (35-53) 46 (44-59) 11 (1-13) 19.4 5.5 7.3 5.8 3.36
E1.15 (ascites) 47 (40-55) 37 (29-44) 16 (10-19)
E1.95 (ascites) 45 (32-58) 46 (32-58) 9 (2-14)
inoculated animals did not influence the growth of El.15
when mixed. When inoculated in the opposite flank, E1.95
did not alter the growth of E1.15. Median tumour volume
doubling times in days are given in Table II.
Cell cycle times
The computed median cell cycle times of the three cell lines
are shown in Table II. Thus the median cell generation time
(Tc) was shortest for the two fastest growing tumours (El.15
and El.95) and longer for the slower growing E1.80.
Table m Relative tumour cell proportions (%) in the inoculated cell
mixtures and in fine-needle aspirations from the tumours asdetermined
by flow cytometric DNA analysis
Cellular composition (%)
Fine-needle tumour aspirate day 14
Cell mixture n Inoculwn Median Range
El.15/El.95 9 69j31 12/88 (0/100-40/60)
El.15SEl.80 9 58/42 85/15 (41/59-100/0)
E1.80/El.95 9 34/66 0 100 (0/100-47/53)
Cell cycle distributions
The distribution of the tumour cells on the cell cycle phases
showed only minor differences between E1.15 and E1.95,
whereas E1.80 had significantly higher proportions of cells in
the Go + GI phases and fewer cells in the S and G2+ M
phases (Table II).
Tumour cell interactions during subcutaneous tumour growth
Changes in the relative cell proportions during solid tumour
growth are shown in Table III. When inoculated in a mixture
with E1.15, E1.95 dominated the tumours after 14 days
(Figure 2). In fine-needle tumour aspirations from tumours
mixed by E1.15 and irradiated E1.95, only E1.15 was detec-
table after 2 weeks of tumour growth, indicating that the
El.95 cells had been killed by the irradiation (data not
shown).
In El.15/El.80 mixed tumours, the proportion of E1.15
increased by a median value of 27%, with a concomitant
decrease in E1.80 (Figure 3).
In the El.80/E1.95 mixed tumours, E1.95 was the
dominating cell line after 2 weeks of tumour growth (Figure
4).
Tumour cell interaction during ascites tumour growth
In order to evaluate tumour cell interaction during in vivo
singl-cell growth, i.e. the tumour cells having no close con-
tact, a 1:1 mixturre of E1.15 and E1.95 was inoculated
intraperitoneally into nine nude mice. Changes in the relative
proportions ofthe cell lines were determined by FCM after 7
days. The total number of tumour cells in the ascitic fluid 7
days after inoculation of 7.5 x 10' cells of either El.15 or
El.95 served as growth parameter (median of nine animals).
On day 7, the median number of E1.15 cells was 4.9 x 10'
(range 3.3-5.6 x 10') and of El.95 4.3 x 10' (range 2.4-
6.9 x 108). The similarity in growth kinetics between E1.15
and E1.95 was further documented by the similarity in cell
cycle distributions (Table II).
The median proportion of diploid host cells was 2% in
ascites from E1.15 and 6% in E1.95 ascites.
The relative proportions of E1.15 and El.95 in the
inoculated mixture were 44% and 56% rmspectively. After 7
days of intraperitoneal growth, the median proportion of
El.15 was 38% (range 36-47%) and of El.95 62% (range
53-64%), as exemplified in Figure 5.
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Fwe 2 DNA histograms (flow cytometric DNA analysis) ofan
intended 1:1 inoculated cell mixture of E1.15 and E1.95 and of a
fi-needle tumour aspirate (median of nine tumours) 14 days
after subcutaneous tumour cell inoculation demonstrating nearly
total dominance of E1.95 in the tumour aspirate. D, diploid host
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mixture of EI.15 and E1.80 and of a fine-needle tumour aspirate
(median of nine tumours) 14 days after subcutaneous tumour cell
inoculation demonstrating nearly total dominance of E1.15 in the
tumour aspirate.
Diescsdom
The experimnts presented in this communication demon-
strated that the parent wild-type cell line E1.95 was able to
dominate a vinblastine-resistant E1.15 subpopulation when
grown subcutaneously in artificaNly mixed tumours in nude
mice. The growth rates (measured by growth curves and day
14 tumour weights), cell cycle phase distributions (measured
by DNA flow cytometry) and cell cycle times (measured by
PLM) were identical for the non-mixed control tumours.
Thus, a difference in growth kinetics of the two tumour cell
lines could not explain the dominating effect, which was only
present when the cells had intimate contact during solid
tumour growth. When the cells were growing as single cells
intraperitoneally in ascitic fluid no such effect could be dem-
onstrated. Also, the domination required viable cells as no
effect was seen if the dominating cells were killed by irradia-
tion. Ascitic fluid from the dominating phenotype El.95 had
no effect on El.15, and no remote effect was seen when the
two tumours were growing in opposite flanks. Both the El.95
and the E1.15 cell lines dominated another Ehrlich cell line,
E1.80, but in this case cell kinetic differences may have
played a role as the El.95 and the E1.15 lines grew faster
than the E1.80.
The El.15[EI.95 and the El.15/El.80 mixed tumours
exhibited growth similar to the dominating phenotypes El.95
and El.15 as evaluated by day 14 tumour weight (Table I).
However, the growth of the El.80/El.95 mixed tumours was
equivalent to the sum of the growth of both phenotypes
(Table I), probably indicating that in these mixed tumours no
Fe 4 DNA histograms (FCM) of an intended 1:1 inoculated
mixture of El.80 and El.95 and of a fine-needle tumour aspirate
(median of nine tumours) 14 days after subcutaneous tumour cell
inoculation showing total dominance of E1.95 in the tumour
aspirate.
growth inhibition of the dominating and faster growing
E1.95 was implemented on the slower growing E1.80, in
other words growth of both cell lines contributed individually
to the growth of this mixed tumour.
Most tumours are heterogeneous in a number of pheno-
typic and often genotypic characteristics appearing during
clonal evolution of a single transformed malignant cell to the
tumour cell society of the resulting tumour mass. During
tumour evolution selection of specific subpopulations may be
the result of interaction between the progeny and the pro-
genitor cells.
Using DNA flow cytometry and growth parameters we
have been able to demonstrate in vivo contact dominance as
an expression of clonal interaction in artificially hetero-
geneous solid tumours during tumour evolution.
Clonal dominance has been reported in murnne tumour
systems using a colony formation assay in selective media
after tumour disaggregation (Miller et al., 1987, 1988), DNA
flow cytometry (Miller et al., 1987), chromosome analysis
(Ichikawa et al., 1989; Staroselsky et al., 1990), androgen
receptor analysis (Ichik-awa et al., 1989) and genetic tagging
(Korczak et al., 1988; Enoki et al., 1990; Samiei &
Waghorne, 1991). In these studies, a mouse mammary
tumour (Miller et al., 1987, 1988; Korczak et al., 1988;
Samiei & Waghorne, 1991), a mouse fibrosarcoma (Enoki et
al., 1990), a mouse melanoma (Staroselsky et al., 1990) and a
Shionogi carcinoma (Ichikawa et al., 1989) have been inves-
tigated. Staroselsky et al. (1990) found dominane by a
metastatic clone and suggested that host immunity played a
major role in their tumour system. Samiei and Waghorne
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cell inoculation showing virtually no changes in the relative pro-
portions of the two cell lines.
(1991), on the other hand, found that clonal dominance was
independent of metastatic ability. Both Miller et al. (1987,
1988) and Ichiklawa et al. (1989) reported results very similar
to ours. In their systems, clonal dominane was seen only
when the cells were growing in cellular contact in solid
tumours in vivo. No interaction was found in vitro. An
immunological mechanism was found unlikely by these
authors. Miller et al. (1988) suggested that a growth-
inhibitory factor is produced by the dominating clone,
Ichikawa et al. (1989) argued against such a mechanism.
Korczak et al. (1988) found that the progeny of a very
limited number of clones dominated in advanced primary
tumours after inoculation of multiple clones and that metas-
tases were of mono- or biclonal origin.
Using phase-contrast microscopy to identify individual col-
onies after tumour disagg gation followed by in vitro
growth, Leith et al. (1985, 1987) have shown that equal
mixtures of two subpopulations of a human colon tumour
grown in nude mice are unstable, and that one clone will
overgrow the other until a stable equilibrium of a 1:9 com-
position is reached. In a human renal cell carcinoma grown
in nude mice Staroselsky et al. (1992) using genetic tagging
demonstrated that distint clones dominated metastases of
different organs and concluded that clonal dominance was
influenced by organ environment.
From the present and the cited studies, it can therefore be
concluded that growth of tumours containing more than one
subpopulation seems to a certain extent and for a certain
period of time to be detrmined by dominating cell popula-
tions. The mechanism of this phenomenon still remains to be
elucidated. However, the results indicate that the cells need
close cellular in vivo contact in order to exert this interaction.
It is likely that the phenomenon is exerted by cell membrane
contact or by short-range mediators.
The phenomenon ofclonal interaction expressed as cellular
dominance among tumour cell subpopulations may explain
fundamental tumour biological characteristics. According to
the clonal evolution theory (Nowell, 1976), genetic instability
of the neoplastic transformed cells results in emergence of
new subpopulations. However, using flow cytometric DNA
analysis on malignant tumours, only one or a few subpopula-
tions are usually found (Vindelov et al., 1980). This could be
a reflection of the limitation in sensitivity of this method
concerning detection of minor DNA aberrations; however,
an alternative explanation could be that pre-existing sub-
populations are extinct or suppressed below the detection
limit of this method by cellular dominance imposed by other
subpopulations. Thus, it is also tempting to explain the
inhibition of the normal haematopoiesis leading to cytopenia,
especially in acute leukaemias, but also in other bone marrow
malignancies such as chronic leukaemias and multiple
myelomas or in bone marrow metastatic lymphoma or car-
cinoma on basis of clonal interaction (dominance) between
the malignant stem cells and the normal haematopoietic stem
cells.
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